These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28235801)

  • 1. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
    Jeong J; VanHouten JN; Kim W; Dann P; Sullivan C; Choi J; Sneddon WB; Friedman PA; Wysolmerski JJ
    J Biol Chem; 2017 Apr; 292(16):6555-6568. PubMed ID: 28235801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.
    Jeong J; Choi J; Kim W; Dann P; Takyar F; Gefter JV; Friedman PA; Wysolmerski JJ
    J Biol Chem; 2019 Jan; 294(3):887-901. PubMed ID: 30463939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer.
    Jeong J; VanHouten JN; Dann P; Kim W; Sullivan C; Yu H; Liotta L; Espina V; Stern DF; Friedman PA; Wysolmerski JJ
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E282-90. PubMed ID: 26729871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland.
    Jeong J; Kim W; Hens J; Dann P; Schedin P; Friedman PA; Wysolmerski JJ
    Endocrinology; 2019 Aug; 160(8):1797-1810. PubMed ID: 31087002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAL2 mediates the formation of stable HER2 signaling complexes within lipid raft-rich membrane protrusions in breast cancer cells.
    Jeong J; Shin JH; Li W; Hong JY; Lim J; Hwang JY; Chung JJ; Yan Q; Liu Y; Choi J; Wysolmerski J
    Cell Rep; 2021 Dec; 37(13):110160. PubMed ID: 34965434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 signaling regulates HER2 localization and membrane retention.
    Jeong J; Kim W; Kim LK; VanHouten J; Wysolmerski JJ
    PLoS One; 2017; 12(4):e0174849. PubMed ID: 28369073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y; Weinman EJ; Dai JL
    Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
    Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
    Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.
    Peters AA; Milevskiy MJ; Lee WC; Curry MC; Smart CE; Saunus JM; Reid L; da Silva L; Marcial DL; Dray E; Brown MA; Lakhani SR; Roberts-Thomson SJ; Monteith GR
    Sci Rep; 2016 May; 6():25505. PubMed ID: 27148852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
    Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
    Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
    Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
    Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Na+-H+ exchanger regulatory factor-1 association and dissociation regulate parathyroid hormone receptor trafficking at membrane microdomains.
    Ardura JA; Wang B; Watkins SC; Vilardaga JP; Friedman PA
    J Biol Chem; 2011 Oct; 286(40):35020-9. PubMed ID: 21832055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
    Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
    Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apical scaffolding protein NHERF2 modulates the localization of alternatively spliced plasma membrane Ca2+ pump 2B variants in polarized epithelial cells.
    Padányi R; Xiong Y; Antalffy G; Lór K; Pászty K; Strehler EE; Enyedi A
    J Biol Chem; 2010 Oct; 285(41):31704-12. PubMed ID: 20663896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism.
    Greco MR; Bon E; Rubino R; Guerra L; Bernabe-Garcia M; Cannone S; Cayuela ML; Ciaccia L; Marionneau-Lambot S; Oullier T; Fromont G; Guibon R; Roger S; Reshkin SJ; Cardone RA
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):26-37. PubMed ID: 30326259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.
    Wheeler DS; Barrick SR; Grubisha MJ; Brufsky AM; Friedman PA; Romero G
    Oncogene; 2011 Jan; 30(1):32-42. PubMed ID: 20802536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer.
    VanHouten J; Sullivan C; Bazinet C; Ryoo T; Camp R; Rimm DL; Chung G; Wysolmerski J
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11405-10. PubMed ID: 20534448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
    Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
    Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NHERF1: molecular brake on the PI3K pathway in breast cancer.
    Georgescu MM
    Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.